A Reference Standard for Analytical Testing of Erythropoietin.

Pharm Res

United States Pharmacopeial Convention, 12601 Twinbrook Pkwy, Rockville, Maryland, 20852, USA.

Published: March 2022

AI Article Synopsis

  • - Erythropoietin (EPO) is a protein that helps produce red blood cells, and a lack of natural EPO can lead to anemia, which can be treated with recombinant Human EPO (rHuEPO).
  • - To ensure the safety and effectiveness of rHuEPO, manufacturers need to use analytical methods for testing different product batches and require reference standards for validation.
  • - The study utilized various analytical techniques to confirm that the rHuEPO reference standard maintains quality, making it suitable for verifying testing methods and equipment.

Article Abstract

Purpose: Erythropoietin (EPO) is a 165 amino acid protein that promotes the proliferation of erythrocytic progenitors. A decrease in endogenous EPO production causes anemia that can be treated with recombinant Human EPO (rHuEPO).

Objective: To ensure the safety and efficacy of the rHuEPO, manufacturers must use analytical methods to demonstrate similarity across batches and between different products. To do this they need reference standards to validate their equipment and methods.

Method: We used peptide mapping, size-exclusion chromatography, glycoprofiling, and isoelectric focusing to analyze a rHuEPO reference standard.

Results: Characterization demonstrates that our rHuEPO reference standard meets the criteria for quality.

Conclusion: The rHuEPO reference standard is fit for purpose as a tool for validating system suitability and methods.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986685PMC
http://dx.doi.org/10.1007/s11095-022-03213-1DOI Listing

Publication Analysis

Top Keywords

reference standard
12
rhuepo reference
12
reference
5
standard analytical
4
analytical testing
4
testing erythropoietin
4
erythropoietin purpose
4
purpose erythropoietin
4
erythropoietin epo
4
epo 165
4

Similar Publications

Detection of spp. DNA in gynaecological samples by quantitative real-time polymerase chain reaction (qPCR) is considered to be the reference diagnostic test for female genital schistosomiasis (FGS). However, qPCR needs expensive laboratory procedures and highly trained technicians.

View Article and Find Full Text PDF

The Polymerase Chain Reaction (PCR) test is a highly sensitive, specific, and rapid diagnostic tool for Chagas disease. Chagas disease is caused by the protozoan flagellate and is endemic to the Americas. While conventional serological methods are still used in the diagnosis of Chagas disease, they are being gradually replaced by molecular methods like PCR.

View Article and Find Full Text PDF

Recommended Opioid Receptor Tool Compounds: Comparative for Receptor Selectivity Profiles and for Pharmacological Antinociceptive Profiles.

ACS Pharmacol Transl Sci

January 2025

Department of Medicinal Chemistry and Institute for Translational Neuroscience, University of Minnesota, Minneapolis, Minnesota 55455, United States.

Opioid agonist ligands bind opioid receptors and stimulate downstream signaling cascades for various biological processes including pain and reward. Historically, before cloning the receptors, muscle contraction assays using isolated organ tissues were used followed by radiolabel ligand binding assays on native tissues. Upon cloning of the opioid G protein-coupled receptors (GPCRs), cell assays using transfected opioid receptor DNA plasmids became the standard practice including S-GTPγS functional and cAMP based assays.

View Article and Find Full Text PDF

Objectives: This study aimed to determine the sequence and eruption chronology of permanent teeth in school children and adolescents of Chennai and compare the findings with an existing standard table. Additionally, the study also attempted to explore the influence of sex, body mass index (BMI), and socioeconomic status (SES) on tooth eruption patterns.

Methods: A cross-sectional study was designed, and 12,650 children aged 5-18 years were selected from thirty-five schools using a multistage random sampling method.

View Article and Find Full Text PDF

The integration of artificial intelligence (AI) into new approach methods (NAMs) for toxicology rep-resents a paradigm shift in chemical safety assessment. Harnessing AI appropriately has enormous potential to streamline validation efforts. This review explores the challenges, opportunities, and future directions for validating AI-based NAMs, highlighting their transformative potential while acknowledging the complexities involved in their implementation and acceptance.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!